UBS Group’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-660
| Closed | -$6K | – | 7424 |
|
|
2018
Q2 | $6K | Buy |
660
+415
| +169% | +$3.77K | ﹤0.01% | 6515 |
|
|
2018
Q1 | $2K | Sell |
245
-3,450
| -93% | -$28.2K | ﹤0.01% | 6700 |
|
|
2017
Q4 | $18K | Buy |
3,695
+3,570
| +2,856% | +$17.4K | ﹤0.01% | 5682 |
|
|
2017
Q3 | $1K | Sell |
125
-2,058
| -94% | -$16.5K | ﹤0.01% | 6719 |
|
|
2017
Q2 | $11K | Buy |
2,183
+2,040
| +1,427% | +$10.3K | ﹤0.01% | 5802 |
|
|
2017
Q1 | $1K | Sell |
143
-3,791
| -96% | -$26.5K | ﹤0.01% | 6593 |
|
|
2016
Q4 | $22K | Sell |
3,934
-695
| -15% | -$3.89K | ﹤0.01% | 5529 |
|
|
2016
Q3 | $25K | Buy |
4,629
+1,129
| +32% | +$6.1K | ﹤0.01% | 5235 |
|
|
2016
Q2 | $25K | Hold |
3,500
| – | – | ﹤0.01% | 5258 |
|
|
2016
Q1 | $23K | Sell |
3,500
-7,948
| -69% | -$52.2K | ﹤0.01% | 5288 |
|
|
2015
Q4 | $118K | Buy |
11,448
+4,733
| +70% | +$48.8K | ﹤0.01% | 4120 |
|
|
2015
Q3 | $79K | Sell |
6,715
-1,486
| -18% | -$17.5K | ﹤0.01% | 4372 |
|
|
2015
Q2 | $75K | Buy |
8,201
+2,987
| +57% | +$27.3K | ﹤0.01% | 4497 |
|
|
2015
Q1 | $33K | Buy |
5,214
+134
| +3% | +$848 | ﹤0.01% | 4991 |
|
|
2014
Q4 | $28K | Buy |
+5,080
| New | +$28K | ﹤0.01% | 5226 |
|